The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Tafenoquine succinate

Australian Public Assessment Report

AusPAR

AusPAR: Tafenoquine succinate [PDF, 1.85 MB]

AusPAR: Tafenoquine succinate [Word, 5.55 MB]

Attachment: Product Information: Tafenoquine succinate [PDF, 308.51 KB]

Attachment: Product Information: Tafenoquine succinate [Word, 134.16 KB]

Attachment: Extract from Clinical Evaluation: Tafenoquine succinate [PDF, 2.11 MB]

Attachment: Extract from Clinical Evaluation: Tafenoquine succinate [Word, 3.35 MB]

Device/Product Name

Kodatef

Active ingredients

Tafenoquine succinate

AusPAR Date

8 April 2019

Published

27 June 2019

Submission Number

PM-2017-02418-1-2

Submission Type

New chemical entity

Decision

Approved